Work

Clinical challenges: myeloma and concomitant type 2 diabetes.

Year: 2013

Type: article

Abstract: Multiple myeloma is a malignant plasma cell disorder that accounts for approximately 10% of all hematologic cancers. It is characterized by accumulation of clonal plasma cells, predominantly in the bone marrow. The prevalence of type 2 diabetes is increasing; therefore, it is expected that there will be an increase in the diagnosis of multiple myeloma with concomitant diabetes mellitus. The treatment of multiple myeloma and diabetes mellitus is multifaceted. The coexistence of the two conditions in a patient forms a major challenge for physicians.

Source: Europe PMC (PubMed Central)

Authors: Yasar Albushra Abdul Rahiem Ahmed, Awad Eltayeb

Institutions: King Abdulaziz Medical City, National Guard Health Affairs, King Khalid University

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W2993757163

FWCI: 0.852

Cites: 60

Cited by: 8

Related to: 10